Figure 3

Reduction of fasting glucose, 2h glucose and glycated haemoglobin levels among tertiles of the genetic score in the rosiglitazone cohort.
Linear regressions under an additive model with adjustment for age, gender, BMI and dosage were adopted. The genetic scores of T1, T2 and T3 groups were ≦21, 22–24, ≧25, respectively. (a) P = 0.0002, β ± SE = −1.13 ± 0.28; (b) P = 0.0014, β ± SE = −1.94 ± 0.58; (c) P = 0.0164, β ± SE = −0.56 ± 0.23.